Novo Nordisk hikes full-year forecast on GLP-1 drug sales https://ift.tt/f0t3o1C

Novo Nordisk was overwhelmed by demand for Wegovy after it was launched in the United States in 2021 and the firm's supply constraints were exacerbated when a contract manufacturer had to temporarily suspend production over manufacturing issues.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/UfLFlYG
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.